Results for:

Infectious Diseases

< Back to all posts

Free COVID Tests Available Soon!

Infectious Diseases Staying Safe Testing and Contact Tracing

The Biden Administration has announced that free COVID-19 tests will once again be available starting in late September. Once available, you will be able to order your free tests by visiting www.covidtests.gov. According to the Dept. of Health & Human Services website, “The COVID-19 Tests will detect current COVID-19 variants and can be used through Read more…

Does my response to vaccines change as I get older?

Aging Infectious Diseases Vaccines

Although our immune response to vaccines decreases with age, vaccines remain crucial for reducing infection severity and risk in older adults. Adjusting vaccine components or administration can help offset this change. TL;DR Our immune systems naturally get weaker with age, making it harder to fight off infections. Numerous accepted vaccination adjustments can compensate for these age-related Read more…

Updated COVID vaccines to be rolled out in the US in September

Infectious Diseases Vaccines

Updated COVID vaccines by Pfizer, Moderna and Novavax are expected to be rolled out in the US this coming September. The CDC recommends that “everyone aged 6 months and older should receive the updated 2024-2025 COVID-19 vaccine to protect against potentially serious health consequences from COVID-19 this fall and winter.” This advice also applies to Read more…

What is immune imprinting, and should the public be worried about it?

Biology/Immunity Infectious Diseases Vaccines

Q: What is immune imprinting, and should the public be worried about it? A: Don’t let statements about imprinting stop you from getting your annual vaccines for COVID and flu. Immune imprinting refers to the fact that our immune response to a vaccine (or infection) is affected by previous exposures to similar vaccines (or infections). Read more…

Does Paxlovid reduce the risk of long COVID?

Infectious Diseases Long COVID Treatments

Unfortunately, data is mixed on the usefulness of Paxlovid for the prevention of long COVID. We need more data, including clinical trials that are carefully designed, to evaluate whether or not there is a benefit. Long COVID, also known as post-acute sequelae of COVID-19, refers to lingering symptoms that emerge in some individuals following a SARS-CoV-2 infection. Read more…